Shionogi Secures BARDA Contract for Drug-Resistant Threats
Program Includes Establishing Pharmaceutical Manufacturing in the U.S., Procurement and Development of Treatment for Infections Caused by Biothreat Pathogens Shionogi & Co., Ltd. (Head Office:...